Schizophrenia👻 Flashcards
(39 cards)
Environmental risk factors
Prenatal problems
Obstetric complications
Urban / city birth
Stressful life events
Drug abuse
Genetic
Susceptibility genes (multiple genes involves in creating predisposition to developing the disorder
Schizophrenia common onset
Late adolescence/ early twenties
Positive symptoms
Hallucinations
Delusions
Disordered thoughts, speech and behaviour
Negative symptoms
Alogia
Affective flattening
Avolition
Anhedonia
Poverty of speech
Lack of motivation
Emotional flattening
Cognitive symptoms
Attention deficit
Memory difficulties
Executive dyfunctioning
Dopamine hypothesis
Increase in dopamine in associative striatum > positive symptoms
Reduction in dopamine transmission in mesocortical pathway > cognitive symptoms
———————————————————————
Excessive DA release in striatum during illness exacerbations.
• Positively correlated with positive symptoms
• Correlated with good treatment response to antipsychotic drugs
• Inadequate DA in frontal cortex
• Associated with deficits in cognitive function e.g. working memory
Treatment Side effects (D2 blocker > antipsychotic)
Blocking dopamine in motor system (there was no problem with the dopamine in the motor system in schizophrenia) = Parkinsonial like side effects
Normally dopamine inhibits prolactin> treatment blocking D2 receptors = hyperprolactinaemia
Efficacy vs side effects
Typical & atypical antipsychotics
Antipsychotics are dopamine D2 receptor antagonists. The postsynaptic neurone think there’s normal levels of dopamine in that pathway.
Typical Antipsychotics (neuroleptics)
• e.g. Haloperidol, Chlorpromazine
• High affinity for dopamine D2 receptors
Atypical Antipsychotics (newer)
• e.g. Clozapine, Olanzapine, Risperidone
• Higher affinity for serotonin (5-HT2) than dopamine D2 receptors
Percentage blockade
Window of occupancy of D2 receptors needed in associative striatum is around 65% blockade to treat positive symptoms.
As you increase dose of antipsychotic , you increase blockage however side effects can also increase.
65%-70%, can begin to see hyperprolactinaemia. Narrow window of D2 occupancy between efficacy and raised prolactin. Some patients find this manageable.
78-80%+, extrapyramidal side effects. Keep blockade under this threshold (80%) so can maintain efficacy without these Parkinsonial side effects eg disrupted normal movement.
Where is there too much dopamine in the brain in schizophrenia
Associative striatum
Receptors
Dopamine activates receptor on the post synaptic neurone. Some are D1 some are D2 receptors. D1 not affected in treatment . Antipsychotic blocks D2 receptor.
Dopamine and prolactin
Dopamine inhibits prolactin release. Increasing inhibition of D2 receptors through treatment )D2 receptor antagonists) increases prolactin. Hyperprolactinaemia. Narrow occupancy window. 65-70%.
Diagnosing
Investigate symptoms and if delusions are true or have any proof. Can you present proof of the opposite.
Symptoms of at least a month.
Psychosis not necessarily schizophrenia eg Illicit drugs can cause psychotic reactions/ dementia / depression
Signs of a problem for 6+ months
Repeat pattern of psychotic episodes overtime. Repeated episodes and durations important criteria.
Gather social, education, family, criminal justice, and medical history info
Prognosis important. The longer it’s left without treatment the worst it is long term.
ICC-11 and DSM-V diagnostic criteria
Antipsychotics and symptoms
They do not cure schizophrenia, they only ALLEVIATE symptoms
Work best when taken regularly. Poor adherence increases risk of relapse by 5 times.
First episode schizophrenia
Individual cognitive behavioural therapy for psychosis (CBTp)
Non pharmacological
In combination with drugs
Can be without antipsychotics but careful review required after a month in case necessary
Family interventions if possible to encourage support and relapse prevention (keeping out of hospital)
Advantage of working for positive, negative & cognitive symptoms (unlike antipsychotics mostly positive)
Arts therapies for negative symptoms
Connecting symptoms with behaviour
First generation (typical) antipsychotics vs second generation (atypicals)
• First generation: sulpiride, flupenthixol, haloperidol, chlorpromazine, zuclopenthixol, trifluoperazine,
perphenazine
• Second generation: amisulpride, quetiapine, risperidone, olanzapine, clozapine, aripiprazole, paliperidone, lurasidone, asenapine
• LITTLE OR NO DIFFERENCE in effectiveness on symptoms. Need to focus side effects & contraindications eg
• Generally less extra-pyramidal side effects (EPSEs) and hyperprolactinaemia for second generation - with notable exceptions
• Metabolic side effects with second generation drugs - ‘metabolic syndrome’
• Antipsychotics have limited effects on negative and cognitive symptoms of schizophrenia
- This is important as these symptoms are correlated more closely with impairments in social/occupational functioning than positive symptoms
Treatment
First episode schizophrenia:
Rule out other causes before diagnosis
Full social, physical, psychiatric, occupational and economical assessment
Offer antipsychotic therapy in conjunction with psychological interventions (individual CBT & family). Consider arts therapy for negative symptoms.
Choice of antipsychotic:
Partnership between patients
Views of carer also
Any antipsychotic history
Consider metabolic, EPSE, cardiovascular, hormonal and other side effects. Could they tolerate specific side effects over others?
Contraindications
Discuss illicit drug abuse / alcohol / smoking / OTC
Maintenance treatment:
May continue for 1-2 years if effective
Relapse risk high if stopped
Careful if withdrawing - slow
Consider depot (injectable antipsychotic as alternative to taking tablets everyday)
Treatment of subsequent acute episodes
•Treat as first episode schizophrenia
• Review diagnosis and existing medications - adherence, adequate dose and duration, family, belief /stigma
•Consider the influence of substance misuse
•May need to switch therapy to alternative antipsychotic
•If already tried first generation drug, switch to second generation ‘atypical’ agent
Maintenance:
• If treatment is efficacious continue with regular review
• Inform patient high risk of relapse
Treatment resistant schizophrenia and clozapine:
•Offer clozapine if not responded adequately to treatment despite the sequential use of adequate doses of at least 2 different antipsychotics, one of which is a second generation ‘atypical’
CORE principles using antipyschotic therapy
• Therapy should be prescribed on a trial basis, for 4-6 weeks at optimum dosage
• Record expected benefits and risks of treatment
• Inform patient that treatment may take 2-3 weeks to work
• Start at lower doses and titrate up according to tolerance/efficacy
• Record the rationale for continuing, changing or stopping medication
• Record the reason for high doses
• Patient-completed scales like
Glasgow Antipsychotic Side-Effect Scale (GASS) can help with monitoring or BEMIB (brief evaluation of medication influences and beliefs)
Extra-pyramidal side effects (EPSEs) to antipsychotics
• EPSE’s are dose related and more likely to occur with typical antipsychotics
• However, higher doses of risperidone and amisulpride (atypical) can also cause EPSEs
• Generally speaking, there are 3 main treatments depending on the type of EPSE
Dystonia
• Muscle spasms in any part of the body, e.g. eye rolling, head/neck twisting swallowing problems
• Treat with anticholinergic or switch to atypical antipsychotic drug
Pseudo-Parkinsonism
Characterised by tremor, rigidity, bradykinesia
Treat by reducing the dose of antipsychotic, or by switching to an atypical drug
Can use anticholinergics short term, review 3/12
Akathisia
• Inner restlessness and desire/compulsion to move - shifting feet, pacing, crossing/uncrossing legs
• Treat by reducing the antipsychotic dose, or switching to an atypical drug
• Anticholinergics are not useful here
• Has been seen with aripiprazole
Tardive dyskinesia
Lip smacking/chewing, tongue protrusion
Approximately 50% of cases are not reversible
Anti-cholinergic drugs make it worse
Stop anticholinergics, reduce antipsychotic dose, withdraw antipsychotic and switch to atypical drug
Side effects to antipsychotic: the metabolic syndrome
Increased weight , blood glucose and lipid profile
Can lead to obesity, diabetes, hyperlipidaemia , macro/microvascular diseases and death
Must monitor / screen carefully, use education / behavioural change, switch drugs if needed
Use statins and treatments for T2DM as required, orlistat and metformin useful for obesity
Most likely seen with clozapine, olanzapine, risperidone, paliperidone, quetiapine
Not likely with most typicals, amisulpride, aripiprazole, lurasidone, asenapine